Seer to Participate in Upcoming November Investor Conferences

Rhea-AI Summary

Seer (Nasdaq: SEER) has announced its participation in two upcoming investor conferences in November. The company will participate in a fireside chat at the Guggenheim Inaugural Healthcare Innovation Conference in Boston on November 11th at 11:30 a.m. ET, and at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York on November 21st at 10:00 a.m. ET.

Both sessions will be available via live webcast on the Investor section of Seer's website at investor.seer.bio, with archived replays accessible after the events.

News Market Reaction – SEER

+7.21%

+7.21% Session move

In the trading session that priced this news, SEER gained 7.21%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company management will be participating in the following investor conferences:

• Guggenheim Inaugural Healthcare Innovation Conference in Boston, MA
  Fireside chat on Monday, November 11^th at 11:30 a.m. Eastern Time
• Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York, NY
  Fireside chat on Thursday, November 21^st at 10:00 a.m. Eastern Time

Live webcasts of the sessions will be available on the Investor section of Seer’s website at investor.seer.bio. Archived replays will be available on the company’s website following the conference.

About Seer
Seer is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Media Contact:
Patrick Schmidt
pr@seer.bio

Investor Contact:
Carrie Mendivil
investor@seer.bio

FAQ

When is Seer (SEER) presenting at the Guggenheim Healthcare Conference in November 2024?

Seer will present at the Guggenheim Inaugural Healthcare Innovation Conference on Monday, November 11th, 2024, at 11:30 a.m. Eastern Time in Boston.

What investor conferences is Seer (SEER) attending in November 2024?

Seer is attending two conferences: the Guggenheim Inaugural Healthcare Innovation Conference in Boston and the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York.

Where can I watch Seer's (SEER) November 2024 investor conference presentations?

Live webcasts of Seer's presentations will be available on the Investor section of their website at investor.seer.bio, with archived replays available after the events.

What time is Seer's (SEER) presentation at the Canaccord Genuity Forum?

Seer will present at the Canaccord Genuity Forum on Thursday, November 21st, 2024, at 10:00 a.m. Eastern Time.